Testing effectiveness (Phase 2)Study completedNCT02057172
What this trial is testing
Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes
Who this might be right for
Type 2 Diabetes
Hanmi Pharmaceutical Company Limited 254